Lexaria Bioscience LEXX
NASDAQ LEXX
$3.15 +0.02 (+0.63%)
As of: Sep 30, 2026 · 12:29 PM EDT

Lexaria Bioscience Corp. (LEXX) Current Leases (2021 - 2024)

Updated

Lexaria Bioscience's Current Leases came in at $28,047 for fiscal Q4 2024 (quarter ended Aug 31, 2024), up 0.9% from $27,794 a year earlier and up 2.9% from the prior quarter.

Analysis

Lexaria Bioscience Corp. (LEXX) Current Leases (2021 - 2024) Analysis & Trends

Going back to fiscal Q4 2021, Lexaria Bioscience's Current Leases data covers 10 quarters.

  • Current Leases carries a three-year compound annual growth rate of -10.7% (FY2021 to FY2024).
  • Going back by fiscal year, Current Leases was $27,794 in FY2023 (-34.7%), $42,587 in FY2022 (+8.1%) and $39,404 in FY2021.
  • The fiscal Q4 2024 figure represents the highest quarterly Current Leases since fiscal Q3 2023.
  • Year-over-year, Current Leases increased in 1 of the last five quarters, with an average decline of 18.8%.
  • Business Quant data shows LEXX's Current Leases at $27,260 (Q3 2024), $26,399 (Q2 2024) and $25,554 (Q1 2024) in the three fiscal quarters before Q4 2024.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Aug 31, 2024 28,047.00
May 31, 2024 27,260.00
Feb 29, 2024 26,399.00
Nov 30, 2023 25,554.00
Aug 31, 2023 27,794.00
May 31, 2023 32,317.00
Feb 28, 2023 29,080.00
Nov 30, 2022 39,629.00
Aug 31, 2022 42,587.00
Aug 31, 2021 39,404.00
API Access

Lexaria Bioscience Corp. Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=LEXX&period=max&api_key=YOUR_API_KEY